Glanzmann thrombasthenia in children from Argentina

Journal of Pediatric Hematology/Oncology

Volumn 18, Issue 1, 1996, Pages 23-28

  Sassetti, Beatriz ^a,d   Lajmanovich, Alicia ^b   Vázquez, Amanda ^c   Vizcarguénaga, María I ^a   Berthier, Rolande ^b   Aversa, Luis ^c   Bustelo, Pedro ^c   Kordich, Lucía ^a  

^a UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

^b INSERM   (France)

^c Hospital Britnico   (Argentina)

^d NONE   (Argentina)

Author keywords

Bleeding disorder; GPIIbIIIa; GT; Pediatrics

Indexed keywords

FIBRINOGEN RECEPTOR;

ADOLESCENT; ARGENTINA; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BLEEDING; BLEEDING TIME; CHILD; CLINICAL ARTICLE; DISEASE CLASSIFICATION; FEMALE; GLANZMANN DISEASE; HUMAN; MALE; PRIORITY JOURNAL; PURPURA; THROMBOCYTE AGGREGATION;

ADOLESCENT; ARGENTINA; BLOTTING, SOUTHERN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; MALE; MEGAKARYOCYTES; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; THROMBASTHENIA;

EID: 0030033341     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199602000-00005     Document Type: Article

References (22)

1. Caen JP, Castaldi PA, Leclerc JC, et al. Congenital bleeding disorders with long bleeding time and normal platelet count. I. Glanzmann's thrombasthenia. Am J Med 1966;41:4.
2. George JN, Caen JP, Nurden AT. Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood 1990;75:1383-95.
3. Phillips DR, Poh Agin P. Platelet membrane defects in Glanzmann's thrombasthenia: evidence for decreased amount of two major glycoproteins. J Clin Invest 1977;60:535-45.
4. Hagen I, Nurden A, Bjerrum OJ, Solum NO, Caen J. Immunochemical evidence for protein abnormalities in platelets from patients with Glanzmann's thrombasthenia and Bernard-Soulier syndrome. J Clin Invest 1980;65:722-31.
5. Kato A, Yamamoto K, Aoki H. Classification of Glanzmann's thrombasthenia based on the intracellular transport pathway of GPI-IbIIIa. Thromb Haemostas 1992;68:615-6.
6. Kunicki TJ, Aster H. Deletion of the platelet-specific alloantigen P1A1 from platelets in Glanzmann's thrombasthenia. J Clin Invest 1978;61:1225-31.
7. Ginsberg MH, Lightsey A, Kunicki TJ, Kaufman A, Marguerie G, Plow EF. Divalent cation regulation of the surface orientation of platelet membrane glycoprotein IIb. Correlation with fibrinogen binding function and definition of a novel variant of Glanzmann's thrombasthenia.J Clin Invest 1986;78:1103.
8. Coller BS, Cheresh DA, Asch E, Seligsohn U. Platelet vitronectin receptor expression differentiates Iraqui-Jewish from Arab patients with Glanzmann thrombasthenia in Israel. Blood 1991;77:75-83.
9. Tomiyama Y, Kashiwagi H, Kosugi S, et al. Demonstration of a marked reduction in the amount of GPIIb in most type II patients with Glanzmann's thrombasthenia. Br J Haematol 1994;87:119-24.
10. Newman PJ, Seligsohn U, Lyman S, Coller BS. The molecular genetic of Glanzmann thrombasthenia in the Iraquí-Jewish and Arab population in Israel. Proc Natl Acad Sci USA 1991;88:3160-4.
11. Burk CD, Newman PJ, Lyman S, Gill J, Coller BS, Poncz M. A deletion in the gene for glycoprotein IIb associated with Glanzmann's thrombasthenia. J Clin Invest 1991;87:270-6.
12. Poncz M, Rifat S, Coller BS, et al. Glanzmann thrombasthenia secondary to a Gly 273-Asp mutation adjacent to the first calcium-binding domain of platelet glycoprotein IIb. J Clin Invest 1994;93:172-9.
13. Berthier R, Marin M, Duperray A, et al. Megakaryocytic development in liquid cultures of cryopreserved leukocytes stem cell concentrates from chronic myelogenous leukemia patients. Exp Hematol 1987;15:750-8.
14. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning. A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982.
15. Uzan G, Frachet P, Lajmanovich A, et al. cDNA clones for human platelet GPIIb corresponding to mRNA for megakaryocytes and HEL cells. Eur J Biochem 1988;171:87-93.
16. Frachet P, Uzan G, Thevenon D, Denadier E, Prandini MH, Marguerie G. GPIIb and GPIIIa aminoacid sequences deduced from human megakaryocytes cDNAs. Mol Biol Rep 1990;14:27-33.
17. Moir J, Ghosh AK, Abdolaziz Z, Knight PM, Masson DY. Immunoenzymatic staining of haematological samples with monoclonal antibodies. Br J Haematol 1983;55:395-410.
18. Duperray A, Berthier R, Chagnon E, et al. Biosynthesis and processing of platelet GPIIbIIIa in human megakaryocytes. J Cell Biol 1987;104:1665-73.
19. Duperray A, Troesch A, Berthier R, et al. Biosynthesis and assembly of platelet GPIIbIIIa in human megakaryocytes: evidence that assembly between pro-GPIIb and GPIIIa is a prerequisite for expression of the complex on the cell surface. Blood 1989;74:1603-11.
20. Laurell CB. Antigen-antibody cross electrophoresis. Anal Biochem 1965;10:358-61.
21. Hagen I, Bjerrum OJ, Solum NO. Characterization of human platelet protein solubilized with Triton X-100 and examined by crossed immunoelectrophoresis. Eur J Biochem 1979;99:9-22.
22. Towbin H, Stachlin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350.